Breaking News
Investing Pro 0
⏰ React to the Market Faster with Custom, Real-Time News Get Started
Close

Catalent Inc (CTLT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Catalent Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
64.27 +1.63    +2.60%
24/03 - Closed. Currency in USD ( Disclaimer )
After Hours
64.54
+0.27
+0.42%
19:30:58 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,375,290
  • Bid/Ask: 64.29 / 69.06
  • Day's Range: 61.04 - 64.42
Catalent Inc 64.27 +1.63 +2.60%

Catalent Inc Company Profile

 
Get an in-depth profile of Catalent Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

19000

Equity Type

ORD

Catalent, Inc. is a provider of development and manufacturing solutions for drug, cell and gene therapies biologics, vaccines, and consumer health products. The Company’s segments include Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. Its Biologics segment provides development and manufacturing for protein, plasmid DNA mRNA, cell therapy, viral vaccines and viral-based gene therapies. Its Softgel and Oral Technologies segment provide formulation, development, and manufacturing services for soft capsules, as well as large-scale manufacturing of oral solid dose forms. Its Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. Its Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for, drugs, biologics and clinical trials.

Contact Information

Address 14 Schoolhouse Road
Somerset, 08873
United States
Phone 732 537 6200
Fax 732 537 6480

Top Executives

Name Age Since Title
Rolf A. Classon 77 2014 Independent Director
Madhavan Balachandran 71 2017 Independent Director
Michael J. Buckley 61 2015 Member of Advisory Board
Donald Eugene Morel 64 2015 Independent Director
Edward R. Robinson - 2015 Member of Advisory Board
John J. Greisch 67 2018 Independent Director
Christa Kreuzburg 63 2018 Independent Director
J. Martin Carroll 73 2015 Independent Lead Director
John R. Chiminski 58 2009 Executive Chair of the Board
Barry C. Buckland 74 2015 Member of Advisory Board
Daniel R. Marshak 65 2015 Member of Advisory Board
Gregory T. Lucier 58 2015 Independent Director
Jack L. Stahl 69 2014 Independent Director
Carolyn R. Bertozzi 55 2015 Member of Scientfic & Advisory Board
Rosemary A. Crane 62 2018 Independent Director
Alessandro Maselli 50 2016 CEO & Director
Matthew R. Stober 55 - Member of the Biologics Advisory Board
Karen A. Flynn 60 2020 Director
David E. Schaffer 53 2019 Member of the Biologics Advisory Board
Michael J. Barber 62 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CTLT Comments

Write your thoughts about Catalent Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Antoine Neaime
Antoine Neaime Nov 02, 2022 3:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will close 49.5 usd
Grégory Vervoort
Grégory Vervoort Aug 12, 2022 3:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mega deal to come with Mithra ?
Hyungjin Lee
Hyungjin Lee Dec 08, 2020 6:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
moderna, regeneron, j&j
Jim Keener
Jim Keener Apr 16, 2020 6:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
solid growth company
Steven Culpepper
Steven Culpepper Jun 21, 2016 4:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Market close 21 Jun appears like frying pan...
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email